|
C6ORF162 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.412590E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.02550000000446E-05 |
| Normal-vs-Stage2 |
1.478550E-03 |
| Normal-vs-Stage3 |
5.316900E-03 |
| Normal-vs-Stage4 |
3.865800E-01 |
| Stage1-vs-Stage2 |
6.860600E-01 |
| Stage1-vs-Stage3 |
9.316200E-01 |
| Stage1-vs-Stage4 |
3.958000E-01 |
| Stage2-vs-Stage3 |
6.807000E-01 |
| Stage2-vs-Stage4 |
3.267600E-01 |
| Stage3-vs-Stage4 |
4.330000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.796860E-04 |
| Normal-vs-AfricanAmerican |
2.002300E-02 |
| Normal-vs-Asian |
1.110170E-01 |
| Caucasian-vs-AfricanAmerican |
2.299200E-01 |
| Caucasian-vs-Asian |
9.076000E-01 |
| AfricanAmerican-vs-Asian |
6.132400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08849999999705E-05 |
| Normal-vs-Female |
2.494100E-02 |
| Male-vs-Female |
1.010190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.977730E-03 |
| Normal-vs-Extreme_Weight |
3.85880000000061E-05 |
| Normal-vs-Obese |
7.760300E-03 |
| Normal-vs-Extreme_Obese |
2.735800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.614600E-01 |
| Normal_Weight-vs-Obese |
4.866000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.032600E-01 |
| Extreme_Weight-vs-Obese |
2.893800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.587830E-01 |
| Obese-vs-Extreme_Obese |
5.327200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.247820E-01 |
| Normal-vs-Age(41-60Yrs) |
1.728070E-02 |
| Normal-vs-Age(61-80Yrs) |
3.631900E-04 |
| Normal-vs-Age(81-100Yrs) |
8.632700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.476800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.153570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.268000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.879670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.569700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.254770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.298400E-03 |
| Normal-VS-Type2 PRCC |
1.29910000001843E-06 |
| Normal-VS-KIRP CIMP |
4.213400E-01 |
| Normal-VS-Unclassified PRCC |
2.175000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.53000000000714E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.885600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.363850E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.988290E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.475600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.598000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.423580E-04 |
| Normal-vs-N1 |
4.364000E-01 |
| Normal-vs-N2 |
7.278800E-03 |
| N0-vs-N1 |
5.145600E-02 |
| N0-vs-N2 |
7.663700E-02 |
| N1-vs-N2 |
5.672300E-02 |
|
|
